Chickenpox: Docile or deadly?
R Soman, S MadanJournal of Postgraduate Medicine 2013 59(2):91-92
CONCLUSIONS: Existing evidence on the safety and effectiveness of MMR/MMRV vaccines support their use for mass immunisation. Campaigns aimed at global eradication should assess epidemiological and socioeconomic situations of the countries as well as the capacity to achieve high vaccination coverage. More evidence is needed to assess whether the protective effect of MMR/MMRV could wane with time since immunisation.PMID:34806766 | DOI:10.1002/14651858.CD004407.pub5
Conclusion: Our study demonstrates an evident variation in hospital admission of viral infections characterized by skin and mucous membrane lesions based on age and gender. Efforts should be directed towards vaccinating high-risk groups, particularly the elderly and females. Moreover, efforts should be focused on vaccinating the young population against varicella, particularly females who are more susceptible to acquiring the infection. Further observational and epidemiological studies are needed to identify other factors associated with increased hospital admission rates.
ConclusionsAfter two years of mandatory vaccination law in Italy, vaccination coverages have reached the 95% threshold only among patients of 24 months of age. Older cohorts still show inadequate vaccination coverages despite the introduction of mandatory vaccination law. Health services at regional level should develop policies and strategies aiming to improve vaccination coverages and to reach herd immunity.Key messagesAfter the introduction on mandatory vaccination, vaccination coverages reached the 95% threshold only among patients of 24 months of age.Health services should develop strategies aiming to improve vaccination coverages.
Condition: Chickenpox Interventions: Biological: Investigational varicella vaccine low potency; Biological: Investigational varicella vaccine medium potency; Biological: Investigational varicella vaccine high potency; Biological: Marketed varicella vaccine Lot 1; Biological: Marketed varicella vaccine Lot 2; Biological: Measles, mumps, and rubella vaccine; Biological: Hepatitis A vaccine; Biological: 13-valent pneumococcal conjugate vaccine Sponsors: GlaxoSmithKline...
Public Health Rep. 2021 Oct 13:333549211050897. doi: 10.1177/00333549211050897. Online ahead of print.ABSTRACTOBJECTIVES: Syndromic surveillance can be used to enhance notifiable disease case-based surveillance. We analyzed features of varicella reported in Georgia to evaluate case detection through syndromic surveillance and to compare varicella reported through syndromic surveillance with varicella reported from all other sources.METHODS: Syndromic surveillance was incorporated into case-based varicella surveillance by the Georgia Department of Public Health (GDPH) in May 2016. A cross-sectional study design evaluated sy...